Tucson, AZ, United States of America

Ya-Ming Xu

USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ya-Ming Xu

Introduction

Ya-Ming Xu is a prominent inventor based in Tucson, Arizona, known for her significant contributions to cancer treatment. With a focus on enhancing the efficacy of cancer therapies, she has developed innovative methods that aim to improve patient outcomes.

Latest Patents

Ya-Ming Xu holds a patent for a method of sensitizing cancer cells to the cytotoxic effects of apoptosis-inducing ligands in cancer treatment. This patent discloses a method that enhances the response of cancer cells in mammals to treatment with an apoptosis-inducing ligand. The method involves contacting the cancer cells with the ligand in conjunction with an effective amount of a specific compound. Additionally, it describes a method of inducing apoptosis in cancer cells by using the compound alongside the apoptosis-inducing ligand, ultimately leading to cell death in cancerous cells.

Career Highlights

Throughout her career, Ya-Ming Xu has worked with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and the University of Arizona. Her work in these institutions has allowed her to contribute to significant advancements in medical research and cancer treatment.

Collaborations

Ya-Ming Xu has collaborated with notable colleagues, including Thomas Joseph Sayers and Alan David Brooks. These partnerships have fostered a collaborative environment that enhances research and innovation in the field of cancer therapy.

Conclusion

Ya-Ming Xu's innovative work in cancer treatment exemplifies the impact of dedicated research and invention in the medical field. Her contributions continue to pave the way for advancements in cancer therapies, ultimately benefiting patients and the healthcare community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…